id ir-10336-24280
recordtype dspace
spelling ir-10336-242802022-05-02T12:37:13Z Guillain–Barré syndrome in Colombia: where do we stand now? Mahecha, María P. Ojeda, Ernesto Vega, Daniel A. Sarmiento-Monroy, Juan C. Anaya, Juan-Manuel Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York. 2017 2020-05-26T00:11:05Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 0257277X https://repository.urosario.edu.co/handle/10336/24280 https://doi.org/10.1007/s12026-016-8816-8 eng info:eu-repo/semantics/openAccess application/pdf Humana Press Inc. instname:Universidad del Rosario
institution EdocUR - Universidad del Rosario
collection DSpace
language Inglés (English)
topic Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
spellingShingle Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
Mahecha, María P.
Ojeda, Ernesto
Vega, Daniel A.
Sarmiento-Monroy, Juan C.
Anaya, Juan-Manuel
Guillain–Barré syndrome in Colombia: where do we stand now?
description Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York.
format Artículo (Article)
author Mahecha, María P.
Ojeda, Ernesto
Vega, Daniel A.
Sarmiento-Monroy, Juan C.
Anaya, Juan-Manuel
author_facet Mahecha, María P.
Ojeda, Ernesto
Vega, Daniel A.
Sarmiento-Monroy, Juan C.
Anaya, Juan-Manuel
author_sort Mahecha, María P.
title Guillain–Barré syndrome in Colombia: where do we stand now?
title_short Guillain–Barré syndrome in Colombia: where do we stand now?
title_full Guillain–Barré syndrome in Colombia: where do we stand now?
title_fullStr Guillain–Barré syndrome in Colombia: where do we stand now?
title_full_unstemmed Guillain–Barré syndrome in Colombia: where do we stand now?
title_sort guillain–barré syndrome in colombia: where do we stand now?
publisher Humana Press Inc.
publishDate 2017
url https://repository.urosario.edu.co/handle/10336/24280
https://doi.org/10.1007/s12026-016-8816-8
_version_ 1740172851864928256
score 12,131701